Emily S Wan1, Ana Kantorowski2, Madeline Polak3, Reema Kadri4, Caroline R Richardson4, David R Gagnon5, Eric Garshick1, Marilyn L Moy6. 1. Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA; Channing Division of Network Medicine, Brigham & Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. 2. Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. 3. Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA. 4. Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA. 5. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA; Massachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, Boston, MA, USA. 6. Pulmonary and Critical Care Medicine Section, VA Boston Healthcare System, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: marilyn.moy@va.gov.
Abstract
BACKGROUND:Technology-based physical activity (PA) interventions have been shown to improve daily step counts and health-related quality of life, but their effect on long-term clinical outcomes like acute exacerbations (AEs) is unknown in persons with COPD. METHODS:U.S. Veterans with stable COPD were randomized (1:1) to either pedometer alone (control) or pedometer plus a website with feedback, goal-setting, disease education, and a community forum (intervention) for 3 months. AEs were assessed every 3 months over a follow-up period of approximately 15 months. Pedometer-assessed daily step counts, health-related quality-of-life (HRQL), and self-efficacy were assessed at baseline, end-of-intervention at 3 months, and during follow-up approximately 6 and 12 months after enrollment. Zero-inflated Poisson models assessed the effect of the intervention on risk for AEs, compared to controls. Generalized linear mixed-effects models for repeated measures examined between-group and within-group changes in daily step count, HRQL, and self-efficacy. RESULTS: There were no significant differences in age, FEV1% predicted, baseline daily step count, AEs the year prior to enrollment, or duration of follow-up between the intervention (n = 57) and control (n = 52) groups. The intervention group had a significantly reduced risk of AEs (rate ratio = 0.51, [95%CI 0.31-0.85]), compared to the control group. There were no significant between-group differences in change in average daily step count, HRQL, or self-efficacy at 6 and 12 months after enrollment. CONCLUSIONS: A 3-month internet-mediated, pedometer-based PA intervention was associated with reduced risk for AEs of COPD over 12-15 months of follow-up. ClinicalTrials.gov identifier: NCT01772082. Published by Elsevier Ltd.
RCT Entities:
BACKGROUND: Technology-based physical activity (PA) interventions have been shown to improve daily step counts and health-related quality of life, but their effect on long-term clinical outcomes like acute exacerbations (AEs) is unknown in persons with COPD. METHODS: U.S. Veterans with stable COPD were randomized (1:1) to either pedometer alone (control) or pedometer plus a website with feedback, goal-setting, disease education, and a community forum (intervention) for 3 months. AEs were assessed every 3 months over a follow-up period of approximately 15 months. Pedometer-assessed daily step counts, health-related quality-of-life (HRQL), and self-efficacy were assessed at baseline, end-of-intervention at 3 months, and during follow-up approximately 6 and 12 months after enrollment. Zero-inflated Poisson models assessed the effect of the intervention on risk for AEs, compared to controls. Generalized linear mixed-effects models for repeated measures examined between-group and within-group changes in daily step count, HRQL, and self-efficacy. RESULTS: There were no significant differences in age, FEV1% predicted, baseline daily step count, AEs the year prior to enrollment, or duration of follow-up between the intervention (n = 57) and control (n = 52) groups. The intervention group had a significantly reduced risk of AEs (rate ratio = 0.51, [95%CI 0.31-0.85]), compared to the control group. There were no significant between-group differences in change in average daily step count, HRQL, or self-efficacy at 6 and 12 months after enrollment. CONCLUSIONS: A 3-month internet-mediated, pedometer-based PA intervention was associated with reduced risk for AEs of COPD over 12-15 months of follow-up. ClinicalTrials.gov identifier: NCT01772082. Published by Elsevier Ltd.
Authors: Michael T Durheim; Patrick J Smith; Michael A Babyak; Stephanie K Mabe; Tereza Martinu; Karen E Welty-Wolf; Charles F Emery; Scott M Palmer; James A Blumenthal Journal: Ann Am Thorac Soc Date: 2015-03
Authors: Marilyn L Moy; Riley J Collins; Carlos H Martinez; Reema Kadri; Pia Roman; Robert G Holleman; Hyungjin Myra Kim; Huong Q Nguyen; Miriam D Cohen; David E Goodrich; Nicholas D Giardino; Caroline R Richardson Journal: Chest Date: 2015-07 Impact factor: 9.410
Authors: Athina Liacos; Christine F McDonald; Ajay Mahal; Catherine J Hill; Annemarie L Lee; Angela T Burge; Rosemary Moore; Caroline Nicolson; Paul O'Halloran; Narelle S Cox; Aroub Lahham; Rebecca Gillies; Anne E Holland Journal: Physiotherapy Date: 2018-08-03 Impact factor: 3.358
Authors: Wytske A Altenburg; Nick H T ten Hacken; Linda Bossenbroek; Huib A M Kerstjens; Mathieu H G de Greef; Johan B Wempe Journal: Respir Med Date: 2014-11-22 Impact factor: 3.415
Authors: Marilyn L Moy; Merilee Teylan; Nicole A Weston; David R Gagnon; Valery A Danilack; Eric Garshick Journal: Chest Date: 2014-03-01 Impact factor: 9.410
Authors: David B Coultas; Bradford E Jackson; Rennie Russo; Jennifer Peoples; Karan P Singh; John Sloan; Minyong Uhm; Jamile A Ashmore; Steven N Blair; Sejong Bae Journal: Ann Am Thorac Soc Date: 2018-04
Authors: Carlos H Martinez; Marilyn L Moy; Huong Q Nguyen; Miriam Cohen; Reema Kadri; Pia Roman; Robert G Holleman; Hyungjin Myra Kim; David E Goodrich; Nicholas D Giardino; Caroline R Richardson Journal: BMC Pulm Med Date: 2014-02-03 Impact factor: 3.317
Authors: Andrés Calvache-Mateo; Laura López-López; Alejandro Heredia-Ciuró; Javier Martín-Núñez; Janet Rodríguez-Torres; Araceli Ortiz-Rubio; Marie Carmen Valenza Journal: Int J Environ Res Public Health Date: 2021-12-02 Impact factor: 3.390
Authors: Rebecca A Raphaely; Maria A Mongiardo; Rebekah L Goldstein; Stephanie A Robinson; Emily S Wan; Marilyn L Moy Journal: BMC Pulm Med Date: 2021-07-15 Impact factor: 3.317
Authors: Kristen M Kraemer; Daniel Litrownik; Marilyn L Moy; Peter M Wayne; Douglas Beach; Elizabeth S Klings; Harry Reyes Nieva; Adlin Pinheiro; Roger B Davis; Gloria Y Yeh Journal: COPD Date: 2021-06-09 Impact factor: 2.069
Authors: Gloria Y Yeh; Daniel Litrownik; Peter M Wayne; Douglas Beach; Elizabeth S Klings; Harry Reyes Nieva; Adlin Pinheiro; Roger B Davis; Marilyn L Moy Journal: BMJ Open Respir Res Date: 2020-11
Authors: Dario Kohlbrenner; Noriane A Sievi; Oliver Senn; Malcolm Kohler; Christian F Clarenbach Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-11-06